Newsroom

New York Methodist Hospital recently participated in the kickoff of the American Cancer Society's (ACS) Cancer Prevention Study-3 (CPS-3) at the ACS's Brooklyn Region Office. The study offers an opportunity for local communities across the United States to actively take part in a historic, multi-year, coordinated research effort. New York Methodist is one of three Brooklyn sites and the only hospital in the borough selected to be a study participant. The ACS is seeking to enroll 300,000 Americans from various racial and ethnic backgrounds into CPS-3. Those wishing to participate must be between the ages of 30 and 65 years and have no prior history of cancer.

The purpose of CPS-3 is to better understand the lifestyle, behavioral, environmental and genetic factors that cause or prevent cancer and ultimately to eliminate cancer as a major health problem in the United States. The study will be administered by the American Cancer Society's Epidemiology Research Program, and involves an initial medical evaluation and responses to questions regarding family history of cancer, lifestyle and other behaviors. After that, participants will simply need to update their information by responding to surveys that they will receive in the mail every few years. Confidentiality is of the utmost importance in CPS-3, so the American Cancer Society has multiple procedures in place to safeguard personal information that is collected.

"NYM is honored to participate in such a far-reaching study in the battle against cancer," said Dennis Buchanan, vice president for human resources at the Hospital, who spoke at the kickoff. "By partnering with the American Cancer Society, and enlisting the help of dedicated Brooklynites, New York Methodist Hospital is going to help make cancer history, in more ways than one."

Those who wish to enroll in CPS-3 should visit cps3brooklyn.org prior to mid-April, to schedule an enrollment appointment and complete a brief survey. There is no cost to participate. Enrollment at NYM will take place on Wednesday, May 8. More information about the study is available on the website.